Analysts expect Carlsmed, Inc. to report revenue of 19.84 M for Q3 26, against a range of 18.49 M to 21.19 M. The most recent reported quarter, Q2 26, came in at 18.94 M, a 12.3% beat against the 16.86 M consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 10.19 M | 12.08 M | 13.07 M | 15.16 M | 16.12 M | 18.94 M | - | - | - | - | - | - | - | - | ||||||
| High Estimate | - | 13.45 M | 11.37 M | 15.22 M | 15.19 M | 17.60 M | 21.19 M | 23.91 M | 23.96 M | 28.64 M | 26.91 M | 32.42 M | 35.94 M | 36.62 M | ||||||
| Low Estimate | - | 12.09 M | 9.62 M | 12.74 M | 13.13 M | 16.13 M | 18.49 M | 19.64 M | 22.33 M | 26.56 M | 24.96 M | 28.90 M | 33.20 M | 33.33 M | ||||||
| Consensus Estimate | - | 12.77 M | 10.49 M | 13.98 M | 14.16 M | 16.86 M | 19.84 M | 21.78 M | 23.15 M | 27.60 M | 25.94 M | 30.66 M | 34.57 M | 34.98 M |
Analysts expect Carlsmed, Inc. to report earnings per share of -0.37 for Q3 26, against a range of -0.40 to -0.34. The most recent reported quarter, Q2 26, came in at -0.39 , in line with the -0.39 consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.39 | -1.47 | -0.40 | -0.32 | -0.32 | -0.39 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | - | -0.81 | -0.48 | -0.39 | -0.34 | -0.37 | -0.34 | -0.32 | -0.30 | -0.37 | -0.17 | -0.27 | -0.30 | -0.30 | ||||||
| Low Estimate | - | -0.89 | -0.54 | -0.43 | -0.40 | -0.41 | -0.40 | -0.38 | -0.34 | -0.43 | -0.19 | -0.31 | -0.32 | -0.34 | ||||||
| Consensus Estimate | - | -0.85 | -0.51 | -0.41 | -0.37 | -0.39 | -0.37 | -0.35 | -0.32 | -0.40 | -0.18 | -0.29 | -0.31 | -0.32 |